- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
IES files appeal in Picker ISO case
Imaging Equipment Services has filed an appeal of a ruling issuedagainst the company in its eight-year legal battle with PickerInternational of Cleveland. The ruling, handed down in July byU.S. District Court Judge Mark Wolf, was a stinging setback tothe
Imaging Equipment Services has filed an appeal of a ruling issuedagainst the company in its eight-year legal battle with PickerInternational of Cleveland. The ruling, handed down in July byU.S. District Court Judge Mark Wolf, was a stinging setback tothe independent service organization that permanently enjoinedthe firm from violating Picker copyrights or misappropriatingPicker trade secrets (SCAN 8/19/95).
IES filed the appeal July 28 in the U.S. Court of Appeals forthe First Circuit in Boston, according to the company. The ISOhopes to overturn Wolf's injunction and charges that Picker'spretrial testimony differs from that given during the trial.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
